Indian drugmakers roll out cheaper Ozempic, Wegovy copies

AI Briefing

• – Indian drugmakers launch cheaper Ozempic and Wegovy copies
• – Key patent expiry reduces treatment costs and intensifies competition in the market
• – Prices estimated to be about 70% lower than brand-name versions